Press Releases Items Per Page 102550 Year All2023202220212020201920182017201620152012 Nov 14, 2023 Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates PDF Version Oct 31, 2023 Galera Announces Receipt of Type A Meeting Minutes and Strategic Update PDF Version Sep 18, 2023 Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem PDF Version Sep 05, 2023 Galera to Participate in the H.C. Wainwright 25th Annual Global Investment Conference PDF Version Aug 14, 2023 Galera Reports Second Quarter 2023 Financial Results and Recent Corporate Updates PDF Version Aug 09, 2023 Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese PDF Version Jun 05, 2023 Galera Presents Additional Chronic Kidney Disease Data from ROMAN Trial at 2023 ASCO Annual Meeting PDF Version May 18, 2023 Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer PDF Version May 11, 2023 Galera Reports First Quarter 2023 Financial Results and Recent Corporate Updates PDF Version May 04, 2023 Galera Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PDF Version
Nov 14, 2023 Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates PDF Version
Sep 18, 2023 Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem PDF Version
Sep 05, 2023 Galera to Participate in the H.C. Wainwright 25th Annual Global Investment Conference PDF Version
Aug 14, 2023 Galera Reports Second Quarter 2023 Financial Results and Recent Corporate Updates PDF Version
Aug 09, 2023 Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganese PDF Version
Jun 05, 2023 Galera Presents Additional Chronic Kidney Disease Data from ROMAN Trial at 2023 ASCO Annual Meeting PDF Version
May 18, 2023 Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer PDF Version
May 11, 2023 Galera Reports First Quarter 2023 Financial Results and Recent Corporate Updates PDF Version
